Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Covington
Johnson and Johnson
US Department of Justice
Julphar
Moodys
McKinsey
Cantor Fitzgerald
Daiichi Sankyo

Generated: July 20, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: GLECAPREVIR; PIBRENTASVIR

« Back to Dashboard

GLECAPREVIR; PIBRENTASVIR

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Abbvie Inc MAVYRET glecaprevir; pibrentasvir TABLET;ORAL 209394 NDA AbbVie Inc. N 0074-2625-01
Abbvie Inc MAVYRET glecaprevir; pibrentasvir TABLET;ORAL 209394 NDA AbbVie Inc. N 0074-2625-28
Abbvie Inc MAVYRET glecaprevir; pibrentasvir TABLET;ORAL 209394 NDA AbbVie Inc. N 0074-2625-56
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Chinese Patent Office
Daiichi Sankyo
Colorcon
Cipla
AstraZeneca
Cantor Fitzgerald
Queensland Health
US Department of Justice